blind everything is relative.  A move from .01 to .025 is

New Post Public Reply Private Reply Replies (1) Message Board
DTL blindinvestor #17329

blind everything is relative.  A move from .01 to .025 is good.  A move from .09 to .0088 is bad.  A recent move from .028 to .04 is only good if it can hold.  A move from .04 to .025 within days is piss poor management of shareholder value because a lousy 10K was released.  Don't get me wrong; the 10K needs to be released at some point.  Do you really think it was an accident that a club was brought in to pump up the PPS earlier this week and right before the 10K was released.  If they hadn't come in to bring the PPS to high .039-.04 levels then manipulation would have had us closing around  today's levels on Monday.  If we were closing at .028's a few days ago then relatively speaking the PPS would have fallen to lower than .02 today IMO which is an entirely different panic zone.  Sub 2's might have carried if further downward so IMO a club was brought in to artificially inflate the PPS.  Easy to do with analysis showing an uptrend.   Managment should have made better decisions last year.  Then they would have had better revenue for last year.  Then the dilution would not  have needed to occur. Then we would have a better looking 10K and the MM's wouldn't have more excuses to manipulate and walk all over TECO's market during all these additional months.  I'm just not as forgiving as some and I look at both sides of the coin.  I can post the bright side as well but that is all forward looking.  We had all kinds of "forward looking bright sides" PR'd last year.  How did that work out for us shareholders?  None of "the facts about these newly announced  wells or Belize have been realized yet so they are only speculation just like in 2012.   I'm worried that the recent 10K facts are a precursor to more of the same due to lack of credibility.  Do shareholders have confident chart indicators other than an uptrend created before the 10K facts were released?  I'm sorry but this analytical uptrend was not baked into the pie otherwise damage control would not have been needed earlier this week and the so-called uptrend would not have been an uptrend if this 10K was out on time i.e. months ago.   These are all artificial indicators IMO but I hope I am wrong and maybe coolnapz can straighten me out.  All I can do is go by the "RUMOR" that things have changed for the better.  Even if I went to Texas what would I see and hear that a video or a PM or phone call couldn't tell me?  I'm sure we have more drilling to do in Texas but will the wells be completed successfully and what is TECO's percentages?  What will the wells cost to drill?  This is what a shareholder requires to make investment decisions.  Not more of "we are planning to drill  XYZ or partner with XYX or purchase XYZ and by the way;  we hope it all turns out ok for you shareholders because we can't control the PPS"!   That said I will hold my shares because I am an eternal optimist but the facts of the past so far speak for themselves about a possible future. 

Treaty Energy Corporation (TECO) Stock Research Links

TECO Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Changshan's Tourism Boom: 22.8% Increase Over Holiday

Updated Category News Views 88

Changshan Grabs Attention This National Day You know, I blinked twice when I saw Changshan's tourist numbers this year. During the 2026 National Day holiday, they managed to snag 503,000 visitors. That's up by a whopping 22.8% from last year. If that doesn't grab your attention, I don't know what will. We're talking record numbers here, folks, and that's the kind of...

Continue Reading
Sempra Shines with Robust Q3 2026 Financials

Updated Category News Views 51

Strong Q3 Numbers Set the Scene It’s not every day you see a company cough up numbers that speak volumes. Sempra’s third quarter for 2026 paints a picture of solid performance, boasting earnings of $877 million or $1.34 per diluted share per GAAP standards. That’s an eye-opener compared to the paltry $77 million or $0.12 per share they reported same time last year....

Continue Reading
VeriSilicon's GCNanoOptimaV Transforms Wearable Tech

Updated Category News Views 105

Revving Up Wearables with Next-Gen Graphics Well, folks, VeriSilicon's at it again, rolling out some cutting-edge technology in the form of their spanking new GCNanoOptimaV GPU IP. If you're scratching your head wondering what this means for your wrist-bound gadgets, hang tight—I'm about to spell it out. Architectural Innovations: Striking the Balance Here's the scoop...

Continue Reading
Jungbunzlauer Introduces Johan Westman to Its Board

Updated Category News Views 35

A Strategic Addition to Jungbunzlauer’s Board In what feels like a significant move, Jungbunzlauer has roped in Johan Westman to join its Board of Directors. The man’s got pedigree—a CEO at AAK AB, a Swedish powerhouse dealing in plant-based oils, he's taking a seat at Jungbunzlauer’s table. So, what does this mean for Jungbunzlauer? Well, the potential for...

Continue Reading
Taiwantrade Introduces AI Sourcing Assistant: ASTRA

Updated Category News Views 121

Revolutionizing AI-Powered Global Sourcing Here's the scoop from Taipei: Taiwantrade's just dropped ASTRA, their brand-spanking-new AI sourcing assistant, and it's got the industry buzzing. When it comes to cutting through the clutter and finding the right supplier, this could change the game for how international buyers scrape deals out of Taiwan. Simplifying Complex...

Continue Reading
APEC CEO Summit Marries Innovation and Global Ties

Updated Category News Views 21

Shenzhen: The Heartbeat of Future Business Shenzhen isn't just a city on the map. It's an exploding innovation powerhouse, a place where global business leaders will rub shoulders this November for the 2026 APEC CEO Summit. This ain't your average conference, my friends. CCPIT (China's national trade pushers) are hosting it from November 17 to 18, promising a powerhouse...

Continue Reading
AAN Seeks Donations to Drive Crucial Brain Research

Updated Category News Views 101

Boosting Brain Horizons: The Need for Donations Urgency clings to the air like smoke around a campfire when it comes to funding brain research. The American Academy of Neurology (AAN) knows this, and they've kicked off their year-end giving campaign, trying to rope in every penny they can muster for the AAN Research Program. With brain diseases lining up like unwanted...

Continue Reading
Seniors and Cybersecurity: Tackling Holiday Threats

Updated Category News Views 90

Battle Against the Holiday Cyber Threats This ain't just about slipping on an ugly sweater this holiday season. The ugly truth is as the colder weather rolls around, so do the cyber vultures—praying on the unsuspecting, especially our seniors. Fraudsters are cranking up the heat, exploiting online shopping sprees, hefty travel plans, and even the warm embrace of a...

Continue Reading
KT&G Soars with Record Profits, Aggressive Share Buybacks

Updated Category News Views 73

KT&G Climbs to New Heights with Record-Setting Q3 If you're eyeballing the markets like a hawk, KT&G (KRX: 033780) just gave you something to squawk about. In the world of stocks, milestones are few and far between, but KT&G is handing out milestones like candy in Q3. They rolled out their numbers for the quarter, and let me tell ya, this was no pie-in-the-sky nonsense....

Continue Reading
New Player in Options Trading: Mercury Alerts Launches

Updated Category News Views 28

Enter Mercury Alerts in a Changing Trading Landscape Damn, if there ain't some days that throw us a curveball, today's one of them. Since Cboe pulled the plug on the beloved Trade Alert, it's like chopping off a trader's lifeline without a backup. Just when everyone was getting cozy with the way Trade Alert fed the options flow into our screens, here comes Harmeet Goindi...

Continue Reading

Top 5 Most Recently Viewed Articles

Join the Upcoming Class Action Against Walgreens for WBA Shareholders

Updated Category News Views 146

Join the Upcoming Class Action Against Walgreens for WBA Shareholders The Gross Law Firm has issued an important notice for shareholders of Walgreens Boots Alliance, Inc. (NASDAQ: WBA) regarding a potential class action lawsuit. If you purchased shares of WBA within the specified dates, you may want to consider your options for participation. Class Action Overview This...

Continue Reading
US Employment Surge Sparks Optimism in Asian Markets

Updated Category News Views 187

US Employment Surge Sparks Optimism in Asian Markets By Jamie McGeever As Asian markets prepare to open, the global economic landscape is shifting dramatically, spurred by astonishing U.S. employment figures. This unexpected data has shifted market perceptions and prompted investors to reconsider their strategies. Strong September Non-Farm Payrolls Report The report on...

Continue Reading
Block, Inc. Investors Urged to Connect with Legal Support Now

Updated Category News Views 161

Understanding Your Rights as a Block, Inc. Investor For investors of Block, Inc. looking to recover their losses, it's crucial to understand the legal avenues available to them. The recent issues surrounding Block should encourage affected investors to seek assistance promptly. How to Recover Losses The Portnoy Law Firm is available to help investors navigate the...

Continue Reading
Key Takeaways from Implantica AG's Annual General Meeting

Updated Category News Views 204

Highlights from Implantica AG's Annual General Meeting On a recent date, the annual general meeting (AGM) of Implantica AG (publ) took place in Ruggell. This important gathering allowed shareholders to review key proposals and resolutions put forth by the board of directors, all of which were adopted. Below is a detailed overview of the notable decisions made during this...

Continue Reading
BRIUMVI's 5-Year Trials Show Significant Efficacy and Safety

Updated Category News Views 116

Key Findings from BRIUMVI's 5-Year Trials TG Therapeutics, Inc. (NASDAQ:TGTX) has revealed impressive results from its long-term Phase 3 trials, ULTIMATE I & II, which focus on BRIUMVI (ublituximab-xiiy) for treating relapsing forms of multiple sclerosis (RMS). These findings were presented at the respected European Committee for Treatment and Research in Multiple...

Continue Reading